NEW YORK (GenomeWeb News) — GeneGo today said that Galapagos will use its MetaCore software for internal research across “several disease areas” including osteoporosis, osteoarthritis, and rheumatoid arthritis.
Galapagos has previously used its adenoviral technology to identify and validate targets in bone and joint diseases, and applying MetaCore to these targets “could allow us to gain valuable insights at the system level,” Galapagos said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.